Literature DB >> 27732800

Pharmacology of Antisense Drugs.

C Frank Bennett1, Brenda F Baker1, Nguyen Pham1, Eric Swayze1, Richard S Geary1.   

Abstract

Recent studies have led to a greater appreciation of the diverse roles RNAs play in maintaining normal cellular function and how they contribute to disease pathology, broadening the number of potential therapeutic targets. Antisense oligonucleotides are the most direct means to target RNA in a selective manner and have become an established platform technology for drug discovery. There are multiple molecular mechanisms by which antisense oligonucleotides can be used to modulate RNAs in cells, including promoting the degradation of the targeted RNA or modulating RNA function without degradation. Antisense drugs utilizing various antisense mechanisms are demonstrating therapeutic potential for the treatment of a broad variety of diseases. This review focuses on some of the advances that have taken place in translating antisense technology from the bench to the clinic.

Entities:  

Keywords:  RNA; RNA interference; RNA splicing; RNase H; antisense oligonucleotides; eteplirsen; mipomersen; nusinersen; oligonucleotide; patisiran

Mesh:

Substances:

Year:  2016        PMID: 27732800     DOI: 10.1146/annurev-pharmtox-010716-104846

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  117 in total

Review 1.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

2.  New twists on long noncoding RNAs: from mobile elements to motile cancer cells.

Authors:  Tuan M Nguyen; Sumayya Alchalabi; Adewunmi Oluwatoyosi; Ali S Ropri; Jason I Herschkowitz; Jeffrey M Rosen
Journal:  RNA Biol       Date:  2020-06-10       Impact factor: 4.652

3.  Recurrent ubiquitin B silencing in gynecological cancers establishes dependence on ubiquitin C.

Authors:  Alexia T Kedves; Scott Gleim; Xiaoyou Liang; Dennis M Bonal; Frederic Sigoillot; Fred Harbinski; Sneha Sanghavi; Christina Benander; Elizabeth George; Prafulla C Gokhale; Quang-De Nguyen; Paul T Kirschmeier; Robert J Distel; Jeremy Jenkins; Michael S Goldberg; William C Forrester
Journal:  J Clin Invest       Date:  2017-11-13       Impact factor: 14.808

Review 4.  Antisense Oligonucleotides Targeting Lipoprotein(a).

Authors:  Anne Langsted; Børge G Nordestgaard
Journal:  Curr Atheroscler Rep       Date:  2019-05-20       Impact factor: 5.113

Review 5.  Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction.

Authors:  Michelle L Hastings; Timothy A Jones
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

6.  Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment.

Authors:  Mohammad A Obeid; Alaa A A Aljabali; Meriem Rezigue; Haneen Amawi; Hanin Alyamani; Shatha N Abdeljaber; Valerie A Ferro
Journal:  Methods Mol Biol       Date:  2021

7.  PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.

Authors:  Hien Tran Zhao; Sagar Damle; Karli Ikeda-Lee; Steven Kuntz; Jian Li; Apoorva Mohan; Aneeza Kim; Gene Hung; Mark A Scheideler; Steven S Scherer; John Svaren; Eric E Swayze; Holly B Kordasiewicz
Journal:  J Clin Invest       Date:  2017-12-04       Impact factor: 14.808

8.  From Influenza Virus Infections to Lupus: Synchronous Estrogen Receptor α and RNA Polymerase II Binding Within the Immunoglobulin Heavy Chain Locus.

Authors:  Bart G Jones; Robert E Sealy; Rhiannon R Penkert; Sherri L Surman; Barbara K Birshtein; Beisi Xu; Geoffrey Neale; Robert W Maul; Patricia J Gearhart; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-02-27       Impact factor: 2.257

9.  Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist.

Authors:  Domenico Girelli; Fabiana Busti; Giacomo Marchi; Nicola Martinelli; Oliviero Olivieri
Journal:  Intern Emerg Med       Date:  2018-03-01       Impact factor: 3.397

10.  A Novel Family of Small Molecules that Enhance the Intracellular Delivery and Pharmacological Effectiveness of Antisense and Splice Switching Oligonucleotides.

Authors:  Ling Wang; Yamuna Ariyarathna; Xin Ming; Bing Yang; Lindsey I James; Silvia M Kreda; Melissa Porter; William Janzen; Rudolph L Juliano
Journal:  ACS Chem Biol       Date:  2017-07-14       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.